baber/WOPTO huggingface dataset:
Patent CA-2576393-A1 (CA)
Title: Nouveaux derives du 3,5-seco-4-nor-cholestane et leurs utilisations
Inventor: DROUOT CYRILLE
IPC: C07C251/44
Filed: 2005-08-19
Abstract: Composé de formule (I) : X + Y = céto, ou X = OH et Y =H, ou X + Y =  groupement oxime ou méthyloxime ; B = OH et C + D =H, ou C + D = radicaux alkyles linéaires ou ramifiés en C1-C4, ou C = H et D = radical alkyle linéaire ou ramifié en C1-C4 ; ou bien B + C = céto et D = méthyle, hydroxyle, ou méthyl aminé ; ou bien B et C = H et D = groupement méthyl aminé ; ou bien B + C = oxime et D = méthyle ; et R = alkyle linéaire ou ramifié en C1-C10 ;  sels, esters et sels des esters, à titre de médicament, applications notamment comme neuroprotecteurs, nouveaux composés de formule (I) et compositions pharmaceutiques.
Patent CA-2577100-A1 (CA)
Title: Chemical compounds
Inventor: GUDMUNDSSON KRISTJAN
IPC: A61K31/47
Filed: 2005-08-12
Abstract: The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.
Patent CA-2577977-A1 (CA)
Title: Device for ejecting pet preforms
Inventor: HANN BERNHARD
IPC: B29C45/33
Filed: 2005-10-03
Abstract: An ejector is used for ejecting PET preforms (6) from an injection moulding tool. The tool comprises a clamping plate (1) to which a mould core (2) is secured. A movable stripping plate (7) is used to move a stripper strip (9), to which are secured threaded slides (10), in the ejection direction A. A yoke support (8) opens the stripper strip (9) by means of a slanted drawing finger (4). Pressurised air L is blown through air channels (11) arranged in the stripper strip (9), into the space between the mould core (2) and the preform (6) to be ejected. For that purpose, the air channels (11) are inclined to a predetermined extent relative to the ejection direction A. This ensures that even particularly large preforms (6) can be securely ejected from the tool.
Patent CA-2578481-A1 (CA)
Inventor: SEBOR PAVEL
IPC: F16K17/04
Filed: 2005-08-22
Abstract: A fluid flow regulator useful with swimming pool suction cleaners includes a flow passage conduit for connection between a suction pump and the pool cleaner. A flow bypass conduit is connected to the flow passage conduit for injecting an ambient fluid into a bypass flow passage. A valve operates within the bypass flow passage with a spring carried entirely within the bypass passage for urging the valve toward a seated position. An adjustment knob acts on the spring for modifying a biasing force on the valve urging the valve toward the seated position in opposition to a pressure from a fluid flow within the flow passage urging the valve to the open position.
Patent CA-2579581-A1 (CA)
Title: Procede d'enrobage de poudres
Inventor: RODIER ELISABETH
IPC: A23L33/15
Filed: 2005-09-08
Abstract: La présente invention concerne un procédé d'enrobage de substances actives solides pulvérulentes caractérisé en ce qu'il comprend les étapes suivantes :  a) fournir (2 ; 3 ; 4) un mélange comprenant au moins un enrobant dans lequel est dissous jusqu'à saturation un fluide supercritique ou subcritique dans des conditions de température et de pression permettant le maintien dudit fluide dans des conditions supercritiques ou subcritiques ; b) fournir (7) des particules individualisées en mouvement d'au moins une substance active solide pulvérulente ; c) mettre en contact (8) le mélange et les particules individualisées en mouvement de substance active dans des conditions de température et de pression assurant simultanément : la détente du fluide supercritique ou subcritique et son retour à l'état gazeux, la pulvérisation de l'enrobant et sa solidification autour des particules individualisées en mouvement de substance active ; d) séparer et récupérer les particules enrobées. (9) La présente invention concerne en outre des microparticules de substance active enrobées, chaque microparticule comprenant successivement un noyau comprenant la substance active et une écorce comprenant l'enrobant, caractérisées en ce qu'elles sont susceptibles d'être obtenues par le procédé  selon la présente invention, en ce que la substance active est solide à  température ambiante et thermosensible, en ce que la taille moyenne du noyau de substance active est inférieure à 50~m.
Patent CA-2580434-A1 (CA)
Title: Container of active substances
Inventor: MUNOZ MARTINEZ JOSE ANTONIO
IPC: A61L9/12
Filed: 2004-08-13
Abstract: Comprises a vessel (1) that houses the active liquid substance to be diffused, such as a fragrance, insecticide or other, through a breathable membrane (2) that closes the vessel (1) and comprises a porous part (3) placed near and parallel to the breathable membrane (2) in order to prevent the deformation of the membrane (2) when a vacuum is generated as the vessel (1) is emptied. The porous part (3) has a number of openings (4) through which passes the liquid to ensure its contact with the membrane (2) at all times for a homogenous evaporation and it occupies part of the volume of the vessel (1), absorbing the active substances, the non-volatile substances remaining in said porous part (3) after the vessel (1) has no more volatile components.
Patent CA-2584554-A1 (CA)
Title: Finishing material panel for construction material
Inventor: KIM JIN SUK
IPC: E04C2/02
Filed: 2007-04-11
Abstract: A finishing material panel for a construction material is disclosed, which comprises an expanded vermiculite of 35~45weight% having heat keeping, adiabatic and inflammable functions, a yellow earth of 5~15weight% or white earth of 5~15weight%, a fibroid component of 5~15weight%, water of 30~40weight%, and at least one sub-material of 5~10weight% selected from the group consisting of silica, charcoal, illite, jade, elva, and aroma. Pores are formed as fibroid is dried, and inflammable effects are excellent owing to expanded vermiculite and silica.
Patent CA-2585512-A1 (CA)
Inventor: OUELLETTE RICHARD
IPC: G10D3/16
Filed: 2007-04-10
Abstract: A pick for playing a non-bowed stringed instrument, such as a guitar, comprises a main body having a front surface and a back surface, and a peripheral edge adjoining the front surface and a back surface. At least a substantial portion of the main body comprises a doming mixture. The pick is formed by providing a thin flat backing having a front face and a back face; placing the thin flat backing onto a curing tray with the back face against the curing tray and the font face facing generally upwardly; introducing a doming mixture onto the front face of the thin flat backing; permitting the doming mixture to cure, thus forming a hardened resin mixture pick having a bottom surface and a domed top surface; and separating the thin flat backing from the hardened pick.
Patent CA-2587123-A1 (CA)
Title: Improvement on a wastebasket structure
Inventor: WANG LONG-SHEH
IPC: E03C1/30
Filed: 2007-04-10
Abstract: A wastebasket includes an outer container, an inner container housed in the outer container, and a lid positioned on top of the outer container; the outer container has a bearing and receiving device for holding a toilet brush and a plunger in position; the bearing and receiving device includes a bearing plate projecting from an inner side of a bottom of the outer container for receiving a plunger; the bearing and receiving device includes a hollow receiving portion on an outer side of the outer container, and a receiving barrel positioned under the hollow receiving portion for receiving a toilet brush as well as receiving foul water dripping from the toilet brush.
Patent CA-2588739-A1 (CA)
Title: Systems for providing a reference plane for mounting an acetabular cup
Inventor: RIES MICHAEL
IPC: A61P19/00
Filed: 2005-12-01
Abstract: Systems and methods for providing a reference for an acetabular cup lane in accordance with embodiments of the invention can include a method performed by a computer-aided surgical navigational system with a display screen and at least one sensor. The method can include detecting at least one array associated with a platform upon which the patient is supported in a supine position. The method can also include defining a surgical reference plane for a surgical procedure associated with an acetabular component, based at least in part on detecting the array associated with the upper surface of the platform. Furthermore, the method can include outputting via the screen at least one user interface for use with the surgical procedure associated with an acetabular component, based at least in part on detecting the array associated with the upper surface of the platform.
Patent CA-2589715-A1 (CA)
Title: Etiquettes rfid a parametres operationnels modifiables
Inventor: FORSTER IAN JAMES
IPC: G06K19/077
Filed: 2005-11-29
Abstract: Une étiquette d'identification de radiofréquence RFID qui comporte une face en papier et un revêtement. D'une part, la face de papier comporte un circuit RFID doté d'un paramètre opérationnel, et d'autre part le revêtement est fixé de manière détachable à la face de papier de telle sorte que, lorsque le revêtement est détaché de la face de papier, le paramètre opérationnel du circuit RFID est modifié à souhait. L'étiquette RFID peut être configurée de manière que le paramètre opérationnel modifié, soit par exemple, une fourchette de lecture ou une direction de propagation. Le circuit RFID peut comporter une puce RFID et une antenne, alors que le revêtement peut comporter un élément électrique modifiant une fourchette de lecture du circuit RFID lorsque le revêtement est fixé sur la face de papier. Plus spécifiquement, l'élément électrique peut être couplé électriquement à l'antenne, lorsque le revêtement est fixé sur la face de papier, avec pour effet de réduire la fourchette de lecture du circuit. Lorsque le revêtement est retiré, l'antenne est découplée à partir de l'élément électrique, ce qui permet son fonctionnement au niveau d'une autre fourchette de lecture, notamment une fourchette opérationnelle spécifiée. Selon une variante, l'élément électrique peut être couplé à l'antenne de circuit RFID de sorte que l'énergie soit propagée depuis l'élément dans une direction orthogonale à la direction normale de propagation de l'antenne.
Patent CA-2590728-A1 (CA)
Inventor: SOSIC ZORAN
IPC: G01N33/53
Filed: 2005-12-05
Abstract: The invention relates to the detection and quantitation of cyclodextrins and cyclodextrin derivatives in solutions comprising a protein. The invention further relates to methods of evaluating pharmaceutical preparations for the presence of residual cyclodextrins.
Patent CA-2591634-A1 (CA)
Inventor: KOSHIBA KUNIHIRO
IPC: G06F15/16
Filed: 2007-06-13
Abstract: A thin client system includes a thin client server, a thin client terminal, and a session management server. The thin client server contains a plurality of execution sections respectively provided for tasks. The session management server is configured to assign the thin client terminal to a specific one of the plurality of execution sections.
Patent CA-2594945-A1 (CA)
Inventor: EBERLE WILSON
IPC: H02M3/155
Filed: 2006-01-31
Abstract: A resonate gate drive circuit for driving at least one power switching device recovers energy loss for charging and discharging the gate capacitance of the power switching devices. The gate drive circuit uses a current source to charge and discharge the gate capacitance with a high current, reducing the switching loss of the power switching device. The gate drive circuit comprises four semiconductor bidirectional conducting switching devices connected in a full-bridge configuration. An inductor connected across the bridge configuration provides the current source. The gate drive circuit may be used in single and dual high-side and low-side, symmetrical or complementary, power converter gate drive applications.
Patent CA-2595411-A1 (CA)
Inventor: HEAFIELD JOANNE
IPC: A61K9/24
Filed: 2006-02-03
Abstract: An oral dosage form, such as a bilayer tablet, comprising a first layer of a first composition and a second layer of a second composition, each composition comprising 5-[4-[2-(N-methyl-N-(2 pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a pharmaceutically acceptable salt or solvate thereof, ('the drug') and a pharmaceutically acceptable carrier therefor, wherein the first and second compositions are arranged to release drug at differing release rates on administration; a process for preparing such a dosage form; and the use of such a dosage form in medicine.
Patent CA-2599421-A1 (CA)
Title: Zirconia- and cerium-oxide-based sintered bead
Inventor: KHODAKOVSKAYA RIMMA
IPC: C04B35/486
Filed: 2006-02-27
Abstract: A sintered bead presenting the following chemical analysis, in percentages by weight and for a total of 100%: ZrO2+HfO2: 78%-85%; CeO2: ≧15%; Al2O3: >0.1%; additive: >0.1%; impurities: <1%; the additive being selected from MnO, MnO2, Fe2O3, CuO, TiO2, Y2O3, Sb2O3, ZnO, and mixtures thereof. Application to microgrinding and to microdispersion.
Patent CA-2600375-A1 (CA)
Inventor: HILL JASON E
IPC: C07K16/28
Filed: 2006-03-06
Abstract: A new ErbB-based ligand binding molecule is disclosed along with its method of preparation and use. The binding molecule is a protein expressed from a recombinant DNA molecule. The protein contains an ErbB extracellular domain that binds to activating ligands. These binding elements act as traps to bind and sequester circulating ligands, thus making them unavailable for binding to cellular ErbB receptors.
Patent CA-2601114-A1 (CA)
Inventor: DIMINO ANDRE A
IPC: A61K9/70
Filed: 2006-03-07
Abstract: A method for enhancing pharmacological, chemical, topical, and cosmetic effects comprising applying at least one reactive agent to a target pathway structure (Step 101) , configuring at least one waveform having at least one waveform parameter (Step 102), selecting a value of said at least one waveform parameter of said at least one waveform to maximize at least one of a signal to noise ratio and a Power signal to noise ratio, in a target pathway structure (Step 103), using said at least one waveform that maximizes said at least one of a signal to noise ratio and a Power signal to noise ratio in a target pathway structure to which said reactive agent has been applied, to generate an electromagnetic signal (Step 104), and coupling said electromagnetic signal to said target pathway structure to modulate said target pathway structure (Step 105) .
Patent CA-2601458-A1 (CA)
Title: Benzimidazolone derivatives as cb2 receptor ligands
Inventor: OMURA HIROFUMI
IPC: C07D471/04
Filed: 2006-03-02
Abstract: This invention relates to compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein: A, B, R1, R2 and R3 are each as described herein, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by CB2 receptor binding activity such as, but not limited to, inflammatory pain, nociceptive pain, neuropathic pain, fibromyalgia, chronic low back pain, visceral pain, acute cerebral ischemia, pain, chronic pain, acute pain, post herpetic neuralgia, neuropathies, neuralgia, diabetic neuropathy, HIV-related neuropathy, nerve injury, rheumatoid arthritic pain, osteoarthritic pain, back pain, cancer pain, dental pain, fibromyalgia, neuritis, sciatica, inflammation, neurodegenerative disease, cough, broncho constriction, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colitis, cerebrovascular ischemia, emesis such as cancer chemotherapy-induced emesis, rheumatoid arthritis, asthma, Crohn's disease, ulcerative colitis, asthma, dermatitis, seasonal allergic rhinitis, gastroesophageal reflux disease (GERD), constipation, diarrhea, functional gastrointestinal disorder, cutaneous T cell lymphoma, multiple sclerosis, osteoarthritis, psoriasis, systemic lupus erythematosus, diabetes, glaucoma, osteoporosis, glomerulonephritis, renal ischemia, nephritis, hepatitis, cerebral stroke, vasculitis, myocardial infarction, cerebral ischemia, reversible airway obstruction, adult respiratory disease syndrome, chronic obstructive pulmonary disease (COPD), cryptogenic fibrosing alveolitis or bronchitis.
Patent CA-2601634-A1 (CA)
Inventor: JOUBERT THIERRY
IPC: F16G11/02
Filed: 2007-09-11
Abstract: The end (300) has an axial housing accommodating an elastic or non-elastic wire rope, where the end is defined by an overall cylindrical outer shell (301) with a fin (311). The shell includes a through opening (317) for accommodating a rope fastener for attaching the rope, where the end cooperates with a bayonet socket end. The fin comprises crown segments with a rectangular cross-section, where the segments are concentric relative to the shell. The opening is machined through the fin, and a cut-out (323) enables a universal end fitting to slightly bend during cooperation with the socket end. An independent claim is also included for a fastener assembly comprising a functional part.
Patent CA-2601698-A1 (CA)
Title: Endoscope with protective sleeve
Inventor: BAR OR YAKOV
IPC: A61B1/00
Filed: 2006-03-01
Abstract: A gastroscopic apparatus for inspecting a body channel is described. The apparatus comprises an insertion tube, an operating handle, a dispenser, which is detachably coupled to the insertion tube, a covering sleeve, which is retained within the dispenser, and a mouthpiece, which is provided with a means for arresting the dispenser within the mouthpiece. Upon arresting the dispenser within the mouthpiece and advancement of the insertion tube within the body channel, the covering sleeve extends from the dispenser and deploys around the insertion tube to protect from contamination that portion of the insertion tube, which had passed the dispenser.
Patent CA-2603391-A1 (CA)
Title: A human immortalised neural precursor cell line
Inventor: JULIUSSON BENGT
IPC: A61K35/12
Filed: 2006-03-30
Abstract: The present invention relates to an immortalised human neural precursor cell line, NGC-407. The cell line has been established from human foetal tissue.  The cell line has been immortalised using a retroviral vector containing the v-myc oncogene. The cell line is a neural progenitor cell line capable of differentiating into to astrocytes and neurons including dopaminergic neurons.  NGC-407 cells are capable of migrating to glioblastoma tumours implanted into rat brains and form gap junctions with the tumour cells. NGC-407 cells expressing a suicide gene can be be used for delivering activated prodrugs in the form of activated nucleoside analogs to tumours.
Patent CA-2603471-A1 (CA)
Inventor: MAGYARI DOUGLAS P
IPC: H04R25/00
Filed: 2006-04-14
Abstract: An acoustic scatterer element (10) incorporates a plurality of convex surfaces (38.1, 38.2) have a plurality of associated curvatures in a corresponding plurality of different directions. A plurality of acoustic scatterer elements of various sizes in a cooperative relationship with one another provide for diffusing acoustic waves in a room (14).
Patent CA-2606638-A1 (CA)
Inventor: MURPHY GREGORY
IPC: G01N35/10
Filed: 2006-05-04
Abstract: A clinical diagnostic sample analyzer for analyzing a sample of a patient is disclosed. The analyzer includes a telescoping closed-tube sampling assembly with a sample probe concentrically housed within a piercing probe and a venting mechanism. The closed-tube sampling assembly is used for aspirating a sample from a sample tube for analysis by a clinical diagnostic sample analyzer.
Patent CA-2606659-A1 (CA)
Inventor: SHIMAZAKI SEIJI
IPC: A61M5/19
Filed: 2007-10-16
Abstract: A combined container-syringe is provided. A bypass chamber and front chamber is provided at a cylindrical tip. The bypass chamber has an inner diameter greater than the outer diameters of front and rear stoppers. The front stopper is inserted into the bypass chamber. The front chamber has an inner diameter equal to the inner diameter of a cylinder or not greater than the outer diameters of the front and rear stoppers and has a volume greater than the volume of a drug solution. A  bypass groove is formed in the inner wall of the bypass chamber and allows the cylinder to communicate with the front chamber while bypassing the front stopper.  Accordingly, it is possible to provide a combined container-syringe enabling observation of the condition of a drug solution filled therein before making an injection and thus to make an injection in a secure manner.
Patent CA-2611934-A1 (CA)
Title: Dengue serotype 1 attenuated strain
Inventor: GUY BRUNO
IPC: C07K14/18
Filed: 2006-05-18
Abstract: The invention relates to live attenuated VDV1 (VERO-Derived Dengue serotype 1 viruse) strains which have been derived from the wild-type dengue-1 strain 16007 by passaging on PDK and sanitization on Vero cells. The invention further relates to a vaccine composition which comprises a VDV1 strain.
Patent CA-2612505-A1 (CA)
Inventor: LI GENYI
IPC: C12P19/34
Filed: 2007-12-28
Abstract: A single base change in the Bn-FAE1.1 gene in the A genome and a two-base deletion in the Bn-FAE1.2 gene in the C genome produce the nearly zero content of erucic acid observed in canola. A BAC clone anchoring Bn-FAE1.1 from a B. rapa BAC library and a BAC clone anchoring Bn-FAE'1.2 from a B. oleracea BAC  library were used in this research. After sequencing the gene flanking regions, it was found that the dissimilarity of the flanking sequences of these two FAE1 homologs facilitated the design of genome specific primers that could amplify the corresponding genome in allotetraploid B. napus. The two-base deletion in the C genome gene was detected as a sequence characterized sequence region (SCAR) marker. To increase the throughput, one genome specific primer was labeled with four fluorescence dyes and combined with 20 different primers to produce PCR products with different fragment sizes. Eventually, a super pool of 80 samples was detected simultaneously, making it possible to analyze over half a million of samples per day using a medium capacity ABI 3100 Genetic Analyzer. This dramatically reduces the cost of marker detection. The single base change in the Bn-FAE1.1 gene was detected as single nucleotide polymorphic (SNP) marker with an ABI SNaPshot kit. A multiplexing primer set was designed by adding a polyT to the 5' primer end to increase SNP  detection throughput through sample pooling. These multiplexed high throughput molecular markers have been successfully implemented in our canola/rapeseed breeding programs.
Patent CA-2614020-A1 (CA)
Inventor: PUROLA VELI-MATTI
IPC: C10G45/02
Filed: 2006-06-29
Abstract: The invention relates to a process for the manufacture of diesel range hydrocarbons wherein a feed is hydrotreated in a hydrotreating step and isomerised in an isomerisation step, and a feed comprising fresh feed containing more than 5 wt% of free fatty acids and at least one diluting agent is hydrotreated at a reaction temperature of 200-400~C, in a hydrotreating reactor in the presence of catalyst, and the ratio of the diluting agent/fresh feed is 5 - 30:1.
Patent CA-2615682-A1 (CA)
Title: Corrosion-resistant, cold-formable, machinable, high strength, martensitic stainless steel
Inventor: MAGEE JOHN H JR
IPC: C22C38/00
Filed: 2006-07-21
Abstract: A corrosion resistant, martensitic steel alloy having very good cold formability is described. The alloy has the following weight percent composition. Carbon 0.10-0.40 Manganese 0.01 -2.0 Silicon 2.0 max. Phosphorus 0.2 max. Sulfur 0.030 max. Chromium 10-15 Nickel 0.5 max. Molybdenum 0.75-4.0 Nitrogen 0.02-0.15 Copper 1 .5-4.0 Titanium 0.01 max. Aluminum 0.01 max.  Niobium + 0.10 max. Tantalum Vanadium 0.20 max. Zirconium less than 0.001 Calcium less than 0.001 The balance of the alloy is essentially iron. Nickel and copper are balanced in the alloy such that the ratio Ni/Cu is less than 0.2. A second embodiment of the alloy contains at least about 0.005% sulfur, selenium, or a combination thereof to provide good machinability.